Filtered By:
Cancer: Cancer
This page shows you your search results in order of date.
Order by Relevance | Date
Total 137 results found since Jan 2013.
Mind-Body Therapies in the Management of Otolaryngologic Disease: A State-of-the-Art Review of Randomized Controlled Trials
CONCLUSION: RCTs of MBTs, including breathing exercises (4), aromatherapy (2), biofeedback (2), meditation, (2), and yoga (2), have been studied in several otolaryngologic conditions, including septoplasty/rhinoplasty (3), head and neck cancer (2), facial palsy (2), and tinnitus (2). Most studies were of moderate risk of bias on appraisal, and each MBT studied was found to significantly reduce subjective and objective distress associated with the otolaryngologic condition in question.IMPLICATIONS FOR PRACTICE: Despite a paucity of strong evidence supporting the universal use of MBTs, our review suggests that MBTs are cost-...
Source: Cancer Control - September 15, 2023 Category: Cancer & Oncology Authors: Dhruv S Kothari Chad A Nieri Zachary G Tanenbaum Lauren A Linker Sanjeet V Rangarajan Source Type: research
Fractionated Stereotactic Radiotherapy compared to Stereotactic Radiosurgery for Vestibular Schwannoma in patients with type-2 Neurofibromatosis
CONCLUSION: In the NF2 population, FRT may yield worse control rates than SRS. Whenever possible, it is preferable to not fractionate treatment for these patients. FRT results, nevertheless, are still good. More and larger prospective trials are warranted.PMID:37657590 | DOI:10.1016/j.wneu.2023.08.110
Source: Cancer Control - September 1, 2023 Category: Cancer & Oncology Authors: Geovanne Pedro Mauro Leila Maria Da R óz Vinicius de Carvalho Gico Eduardo Weltman Evandro C ésar de Souza Eberval Gadelha Figueiredo Manoel Jacobsen Teixeira Source Type: research
Cancers, Vol. 15, Pages 4365: Sex Differences in Vestibular Schwannoma
In conclusion, self-rated QoL in VS is significantly affected by sex and surgery. This should be taken into account when counseling VS patients regarding observation, radiotherapy, and surgery.
Source: Cancers - September 1, 2023 Category: Cancer & Oncology Authors: Kathrin Machetanz Sophie S. Wang Linda Oberle Marcos Tatagiba Georgios Naros Tags: Article Source Type: research
The 5-Steps to Relieve Tinnitus
My patient T.K. was a wreck. He looked like he hadn’t slept in a week. I asked him what was going on.
“It’s nothing you can fix, doc,” he said. “I’ve been to three specialists, and they all told me the same thing…
“I’ve got tinnitus, and I just have to live with it.”
Luckily, I was able to help him.
Tinnitus is an aggravating, nerve-racking, and unseen condition.
The constant ringing in your ears robs you of sleep, makes you miserable as it drowns out your hearing, and, over time, makes you more prone to illness. Tinnitus also shatters your focus and concentration.
Sadly, up to 25% of the U.S. populatio...
Source: Al Sears, MD Natural Remedies - August 9, 2023 Category: Complementary Medicine Authors: Jacob Tags: Anti-Aging Source Type: news
The relevance of ototoxicity induced by radiotherapy
The risk of ototoxicity, characterized by hearing impairment, tinnitus, or middle ear inflammation, is elevated in both child and adult cancer survivors who have undergone head-neck or brain radiation, or a co...
Source: Radiation Oncology - June 3, 2023 Category: Cancer & Oncology Authors: Yan Huang, Hong Zhou, Fenglan An, Aimei Zhao, Jian Wu, Meihua Wang and Judong Luo Tags: Research Source Type: research
Hearing screening and amplifier uptake results in a multidisciplinary head and neck cancer survivorship clinic
ConclusionsThe data from 1176 survivors of HNC seen by audiology over the past few years as part of the UPMC HNC Survivorship Clinic support the need for hearing management in this population to improve communication during and after the Survivorship Clinic visit.Implications for Cancer SurvivorsSurvivors of HNC have a high prevalence of greater than mild hearing loss and tinnitus (both issues known to negatively impact health-related communication and quality of life). This manuscript describes a hearing screening program within a Survivorship Clinic that identifies individuals in need of non-custom amplification during t...
Source: Journal of Cancer Survivorship - May 25, 2023 Category: Cancer & Oncology Source Type: research
Association Between Chronic Tinnitus and Brain-Derived Neurotrophic Factor Antisense RNA Polymorphisms Linked to the Val66Met Polymorphism in BDNF
In conclusion, four of the polymorphisms in BDNF-AS gene (rs955946, rs1488830, rs1519480, and rs10767658) are potential gene loci that may play a role in the auditory pathway and affect auditory performance.PMID:37230202 | DOI:10.1016/j.gene.2023.147507
Source: Cancer Control - May 25, 2023 Category: Cancer & Oncology Authors: Buse Yuksel Murat Dogan Olcay Boyacioglu Mustafa Sahin Seda Orenay-Boyacioglu Source Type: research
Acori Tatarinowii Rhizoma: A comprehensive review of its chemical composition, pharmacology, pharmacokinetics and toxicity
Acori Tatarinowii Rhizoma (ATR, Shi Chang Pu in Chinese), a natural product with multiple targets in various diseases. This review provides the comprehensive summary of the chemical composition, pharmacological effects, pharmacokinetics parameters and toxicity of ATR. The results indicated that ATR possesses a wide spectrum of chemical composition, including volatile oil, terpenoids, organic acids, flavonoids, amino acids, lignin, carbohydrates and so on. Accumulating evidence from various studies has shown that ATR exerts a wide range of pharmacological properties, including protecting nerve cells, alleviating learning an...
Source: Frontiers in Pharmacology - March 16, 2023 Category: Drugs & Pharmacology Source Type: research
The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review
ConclusionsOtotoxicity has a negative long-term impact on multiple areas of life for adults and children LWBC. This can compromise their quality of life.Implications for cancer survivorsIncreased awareness, monitoring and education surrounding these issues may lead to earlier intervention and better management of ototoxicity, enhancing the quality of life of people LWBC.
Source: Journal of Cancer Survivorship - January 13, 2023 Category: Cancer & Oncology Source Type: research
Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy
ConclusionsOtotoxicity risk factors included age, cisplatin dose, cardiovascular risk factors, and family history of hearing loss. Three of four TC survivors report some type of ototoxicity; thus, follow-up of cisplatin-treated survivors should include routine assessment for ototoxicity with provision of indicated treatments.Implications for Cancer SurvivorsSurvivors should be aware of risk factors associated with ototoxicity. Referrals to audiologists before, during, and after cisplatin treatment is recommended.
Source: Journal of Cancer Survivorship - January 13, 2023 Category: Cancer & Oncology Source Type: research
Tuning in to Your Most-Ignored Sense Can Make You Happier
Somewhere along the long, winding road of evolution, a bunch of genes got together in a conference room and decided it would probably be most optimal for human survival if we were forced to take in every sound all around us at all times. Thus, the ear was born. Unlike their neighbors the eyes, the ears came with no on/off option. This is a great safety feature if you’re living in a cave surrounded by predators, but it’s since been hijacked by a world in which you’re more likely to find yourself trying to sleep through a neighbor’s car alarm blaring at 1 A.M.
[time-brightcove not-tgx=”trueR...
Source: TIME: Health - January 6, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized healthscienceclimate Mental Health Wellbeing Source Type: news
Risk factors associated with cisplatin ‐induced ototoxicity in Japanese patients with solid tumors
ConclusionNo patient discontinued treatment owing to hearing impairment. The total cisplatin dose was considered related to post-treatment hearing impairment frequency in Japanese patients. However, routine audiometric monitoring is recommended during high-dose cisplatin-based chemotherapy.
Source: Cancer Medicine - December 26, 2022 Category: Cancer & Oncology Authors: Hideaki Okada,
Koichi Kitagawa Tags: RESEARCH ARTICLE Source Type: research
Effects of Apatinib Mesylate Monotherapy on the Incidence of Adverse Reactions and Immune Function in Patients with Breast Cancer after Radical Mastectomy
CONCLUSION: Apatinib mesylate monotherapy after radical mastectomy yields a high DCR, a lower incidence of adverse events, and improved immune recovery. Clinical trials are, however, required prior to clinical promotion.PMID:35990841 | PMC:PMC9385297 | DOI:10.1155/2022/4022282
Source: Evidence-based Complementary and Alternative Medicine - August 22, 2022 Category: Complementary Medicine Authors: Sen Lin Meichun Zang Source Type: research
Say What? Hearing Issues Common After Taxane-Based Chemo Say What? Hearing Issues Common After Taxane-Based Chemo
Hearing loss and tinnitus occur often in cancer survivors who received a regimen with a taxane, a platinum, or both, a new study finds.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - August 4, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
